VITA 34 AG/€V3V
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About VITA 34 AG
VITA 34 AG is a biotechnology company specializing in the collection, processing, and storage of stem cells from umbilical cord blood and tissue. Founded in 1997, the company is headquartered in Leipzig, Germany, and operates primarily in the biobanking industry. VITA 34's services offer potential medical applications for regenerative medicine and are designed to support future therapeutic use. The company maintains a strong presence in Europe and emphasizes rigorous quality standards in its storage processes. VITA 34's strategic focus on the growing biobanking sector positions it to leverage advancements in personalized medicine.
Ticker
€V3V
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
766
ISIN
DE000A0BL849
Website
VITA 34 AG Metrics
BasicAdvanced
€78M
-
-€0.68
0.61
-
Price and volume
Market cap
€78M
Beta
0.61
52-week high
€4.36
52-week low
€3.86
Financial strength
Current ratio
0.763
Quick ratio
0.673
Long term debt to equity
95.275
Total debt to equity
138.942
Interest coverage (TTM)
-8.20%
Profitability
EBITDA (TTM)
-3.627
Gross margin (TTM)
26.15%
Net profit margin (TTM)
-14.02%
Operating margin (TTM)
-10.66%
Effective tax rate (TTM)
-37.63%
Revenue per employee (TTM)
€110,000
Management effectiveness
Return on assets (TTM)
-3.67%
Return on equity (TTM)
-69.54%
Valuation
Price to revenue (TTM)
0.908
Price to book
5.48
Price to tangible book (TTM)
-2.65
Price to free cash flow (TTM)
20.682
Free cash flow yield (TTM)
4.84%
Free cash flow per share (TTM)
21.27%
Growth
Revenue change (TTM)
10.29%
Earnings per share change (TTM)
-4,609.93%
3-year revenue growth (CAGR)
30.35%
10-year revenue growth (CAGR)
20.18%
3-year earnings per share growth (CAGR)
-2.26%
10-year earnings per share growth (CAGR)
5.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for VITA 34 AG stock?
VITA 34 AG (V3V) has a market cap of €78M as of July 01, 2025.
What is the P/E ratio for VITA 34 AG stock?
The price to earnings (P/E) ratio for VITA 34 AG (V3V) stock is 0 as of July 01, 2025.
Does VITA 34 AG stock pay dividends?
No, VITA 34 AG (V3V) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next VITA 34 AG dividend payment date?
VITA 34 AG (V3V) stock does not pay dividends to its shareholders.
What is the beta indicator for VITA 34 AG?
VITA 34 AG (V3V) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.